Skip to main content

Day: December 2, 2021

Home Franchise Concepts, a JM Family Enterprises Subsidiary, Adds Aussie Pet Mobile to its Family of Brands

Scott Barrett HeadshotScott Barrett, senior vice president at JM Family Enterprises and president of Home Franchise ConceptsLeon Feuerberg HeadshotLeon Feuerberg, president of Aussie Pet MobileDEERFIELD BEACH, Fla., Dec. 02, 2021 (GLOBE NEWSWIRE) — Home Franchise Concepts (HFC), a subsidiary of JM Family Enterprises, has acquired Aussie Pet Mobile, a leading franchisor of mobile pet grooming services for dogs and cats. Aussie Pet Mobile becomes the eighth brand in the Home Franchise Concepts portfolio, joining Budget Blinds, Tailored Living featuring PremierGarage, Concrete Craft, AdvantaClean, Kitchen Tune-Up, Bath Tune-Up and Two Maids & A Mop. While at-home pet care is a new field for HFC, it is a symbiotic fit as the company continues to capitalize on its success in the franchise business...

Continue reading

(CORRECTION) IQST – iQSTEL Announces $58 Million YTD Revenue and Revises 2021 Revenue Forecast Up 4% To $63 Million

New York, NY, Dec. 02, 2021 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today announced reaching $58 million in revenue year-to-date as of November 30, 2021. The revenue for the month of November was $6.5 million. Management now expects to exceed its $60.5 million revenue forecast for FY-2021 and is revising the forecast upward by approximately 4% to $63 million. Mr. Iglesias commented, “We are pleased with the ongoing growth of the iQSTEL Telecom Business and with the pending acquisition of Smartbiz, our preliminary revenue forecast for our Telecom Business alone, is $80 million.  We anticipate higher margin revenue from our other business lines, IoT, Blockchain Platform, EV Motorcycles, and Fintech to begin ramping up in 2022 contributing to both the top and bottom line.  As pleased as we are with the 2021 financial results,...

Continue reading

PHBI – Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset

Carson City, Nevada, Dec. 02, 2021 (GLOBE NEWSWIRE) — Pharmagreen Biotech, Inc., (OTC Pink: PHBI), today released a management update from CEO Peter Wojcik. The update is the first in a series of narratives breaking out the company’s strategy as it begins to convert the revenue potential of its proprietary intellectual property into realized revenue. The update is included in its entirety below: CEO Peter Wojcik Strategic Update Pharmagreen has reached an exciting transition stage where our proven intellectual property asset will now be leveraged to begin generating and growing revenue. Pharmagreen has a proprietary tissue culture process that can be applied to the cannabis industry to increase the scalability of industrial grow operations at the same time preserving genetic purity and enhancing quality production. Pharmagreen...

Continue reading

Vivos Inc Obtains Feedback from the FDA on Clinical Testing of RadioGel™

Richland WA, Dec. 02, 2021 (GLOBE NEWSWIRE) — Vivos Inc. (OTCQB: RDGL), on November 30 Vivos Inc met with the Food and Drug Administration to obtain suggestions on improving the current draft of the Investigational Device Exemption, which is necessary to initiate clinical testing in humans. Two physicians from Mayo Clinic, Dr. Paz Fumagalli and Dr. Beau Toskich did an excellent job presenting the need for Radiogel™ to treat recurrent thyroid cancer and to answer a range of questions from the new FDA review team. The FDA was very supportive and had suggested this Q-Submission path for rapid turnaround and dialog. The FDA provided many helpful suggestions on a range of subjects from labeling to dosimetry to the Mayo protocol for clinical testing, and the need for some additional specific testing. They suggested having another Q-Sub...

Continue reading

IMAC Holdings Strengthens Executive Team to Accommodate Rapid Growth

Founding Partner of Ozzie Smith IMAC Regeneration Center Promoted to IMAC Chief of Staff BRENTWOOD, Tenn., Dec. 02, 2021 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”) today announces a promotion and multiple new hires to accommodate the Company’s rapid growth in both IMAC Regeneration Centers and The Back Space subsidiary. Sandy Miller, founding partner of IMAC’s Ozzie Smith IMAC Regeneration Center in 2015, has been promoted to the position of Chief of Staff for IMAC. Ms. Miller has served as Vice President of Clinical Development for IMAC over the past three years. The Company has also hired Norleidy Hernandez as Human Resources Director. Ms. Hernandez joins IMAC from St. Charles Surgical Hospital where she served as Director of Human Resources. Additionally, Frank DeVito, III, has been hired...

Continue reading

V Group Embarks on New Venture

Carlsbad, CA, Dec. 02, 2021 (GLOBE NEWSWIRE) — V Group, Inc. (OTC Pink: VGID) is delighted to announce the newest venture and opportunity secured by V Group for the benefit of V Group shareholders. On December 1st, 2021, V Group signed a Letter of Intent (LOI) to purchase a dynamic company in the Health Care Industry. This company is positioned in the highly lucrative and rapidly growing Elderly In-Home Care Industry. The In-Home Health Care Industry generated approximately 135 billion dollars domestically in 2020 and is expected to increasingly grow as the population becomes older and they desire a more compassionate and personal approach to Elderly care. Studies show that when given the choice, the overwhelming majority of Elderly greatly prefer the comfort, convenience and security of their home rather than an assisted living...

Continue reading

Ayurcann Wins Two Leading Awards in Canada for Extraction Facility and Toll Processing Facility of the Year

Toronto, Ontario, Dec. 02, 2021 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE: AYUR, OTCQB: CDCLF, FSE:3ZQ0) (the “Company” or “Ayurcann”) a Canadian cannabis extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to announce that it has won Extraction Facility of the Year and Toll Processing Facility of the Year at the 2021 GrowUp Awards Gala in Niagara Falls, Ontario, Canada. Ayurcann is a growing extraction company continuously incorporating new and strategic business approaches to maintain their industry leading services. With an annual extraction capacity of up to 300,000 kg, Ayurcann can supply bulk or formulated THC and CBD products to industry leaders while also offering a competitive advantage through their white labelling services. Roman...

Continue reading

Simmons First National Corporation Issues Supplemental Information Regarding Acquisition of Spirit of Texas Bancshares, Inc.

PINE BLUFF, Ark., Dec. 02, 2021 (GLOBE NEWSWIRE) — On November 19, 2021, Simmons First National Corporation (NASDAQ: SFNC) (“Simmons” or “Company”) and Spirit of Texas Bancshares, Inc. (NASDAQ: STXB) (“Spirit”) announced the execution of a definitive merger agreement (the “Merger Agreement”) pursuant to which Simmons will acquire Spirit, and its wholly-owned subsidiary, Spirit of Texas Bank SSB (the “Proposed Transaction”), in a transaction consisting of a mixture of cash and Simmons’ common stock with an aggregate value of approximately $581 million, based on the Simmons’ closing stock price of $31.73 on November 17, 2021.   As previously disclosed, under the terms of the Merger Agreement, Simmons estimates it will issue approximately 18,325,000 shares of its common stock, subject to certain conditions and potential adjustments,...

Continue reading

Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol

WOBURN, Mass., Dec. 02, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the U.S. patent application number 17/234,490, titled “Illumination for Photodynamic Therapy,” that covers an innovative, pain-reducing illumination protocol for photodynamic therapy (PDT). “This patented illumination protocol demonstrates Biofrontera’s commitment to the patients’ need for innovative treatments. The patent also strengthens Biofrontera’s competitiveness for our FDA-approved combination product, Ameluz® together with our PDT-lamp BF-RhodoLED® and its successor model RhodoLED® XL in the U.S. by providing an opportunity to pursue label...

Continue reading

EZFILL LAUNCHES HOLIDAY GIFT OF FUEL TO HELP CUSTOMERS COMBAT RISING FUEL PRICES THIS WINTER

—On-Demand Fuel Delivery, the Perfect Gift for Miami-Bound Snowbirds, College Students and Residents Looking to Eliminate Visits to the Gas Station— —$10 Discount on First Order for Gift Receivers and Givers— MIAMI, FL, Dec. 02, 2021 (GLOBE NEWSWIRE) — EzFill Holdings, Inc. (“EzFill” or the “Company”) (NASDAQ: EZFL), a pioneer and emerging leader in the fast-growing on-demand mobile fuel industry, announced today the launch of its holiday EzFill Gift of Fuel to help snowbirds, college students, and full-time residents in the Miami area save on gas and reduce or eliminate visits to the gas station this winter. In the spirit of giving, and to help offset the rising cost of gas, the Company is enabling existing customers to gift a free credit of $10 to new customers. EzFill will then credit the gift giver $10...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.